Research and Development

The US presidential election is mere weeks away, and the pharmaceutical industry and drug pricing have occupied quite a large …

Novartis has signed an agreement with Cerulean Pharma, worth a potential $1.2 billion depending on milestones met, to co-develop nanoparticle-drug …

NICE has given its approval to another indication for Celgene’s Otezla (apremilast), meaning NHS patients now have access to the …

MSD, known as Merck in the US, released news of the successful meeting of its primary endpoints in its Phase …

Oxford Genetics has moved its operations to the Medawar centre in the city, upscaling its infrastructure and staff to keep …

Indian drug firm Sun Pharma is set to join forces with the International Centre for Generic Engineering and Biotechnology (ICGEB) …

Eli Lilly has announced a project, known as Lilly 30×30, which is a five-year, $90 million investment to improve access …

Coming off the back of earlier positive news this month, Roche has revealed that their drug, Tecentriq, has been given …

Contract development and manufacturing firm Recipharm has announced plans to invest five million Swedish Krona (SEK) in a new GLP-compliant …

The FDA has continued their push to provide funding for experimental clinical trials into treatments of rare diseases. The FDA, …

Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …

Wickham Laboratories announces that the United States Food and Drug Administration (FDA) inspection conducted 15th-17th of February 2016 has now …

Kite Pharma announced on 13 October that it had appointed Chris Nowers as its Head of Europe. Nowers will be …

Nordic Nanovector announced on 12 October that Joanna Horobin was elected to its Board as non-executive director at the company’s …

Speaking at its 2016 Capital Market Day about the progress it had made towards its 2018 objectives, CEO Stefan Oschmann …